BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 28076248)

  • 1. Prediabetes Screening and Treatment in Diabetes Prevention: The Impact of Physician Attitudes.
    Mainous AG; Tanner RJ; Scuderi CB; Porter M; Carek PJ
    J Am Board Fam Med; 2016 Nov; 29(6):663-671. PubMed ID: 28076248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediabetes Knowledge, Attitudes, and Practices at an Academic Family Medicine Practice.
    Keck JW; Thomas AR; Hieronymus L; Roper KL
    J Am Board Fam Med; 2019; 32(4):505-512. PubMed ID: 31300570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding type 2 diabetes mellitus screening practices among primary care physicians: a qualitative chart-stimulated recall study.
    Hafez D; Nelson DB; Martin EG; Cohen AJ; Northway R; Kullgren JT
    BMC Fam Pract; 2017 Apr; 18(1):50. PubMed ID: 28376802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Survey of Primary Care Physicians' Knowledge, Practices, and Perceptions of Prediabetes.
    Tseng E; Greer RC; O'Rourke P; Yeh HC; McGuire MM; Albright AL; Marsteller JA; Clark JM; Maruthur NM
    J Gen Intern Med; 2019 Nov; 34(11):2475-2481. PubMed ID: 31502095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study.
    Moin T; Li J; Duru OK; Ettner S; Turk N; Keckhafer A; Ho S; Mangione CM
    Ann Intern Med; 2015 Apr; 162(8):542-8. PubMed ID: 25894024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Primary Care Physicians' Attitudes Toward Understanding Clinical Practice Guidelines for Diabetes Screening.
    Alexander PE; Li SA; Tonelli M; Guyatt G
    Can J Diabetes; 2016 Dec; 40(6):580-585. PubMed ID: 27590082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
    Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
    Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Diabetes Screening and Prediabetes Treatment during Office Visits in the US.
    Shealy KM; Wu J; Waites J; Taylor NA; Blair Sarbacker G
    J Am Board Fam Med; 2019; 32(2):209-217. PubMed ID: 30850457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of prediabetes: a comparison of the treatment approaches utilized by a family practice clinic and an internal medicine/endocrinology practice.
    Anderson ZL; Scopelliti EM; Trompeter JM; Havrda DE
    J Pharm Pract; 2015 Feb; 28(1):86-92. PubMed ID: 24326412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing Patterns of Metformin in High-risk Patients with Prediabetes.
    Stirling DL; Onor I; Sarpong D; Rapp KI; Crawford LD
    J La State Med Soc; 2015; 167(6):257-62. PubMed ID: 26741685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediabetes Diagnosis and Treatment in Primary Care.
    Mainous AG; Tanner RJ; Baker R
    J Am Board Fam Med; 2016; 29(2):283-5. PubMed ID: 26957387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of metformin for type 2 diabetes prevention: Observational multicenter study from Saudi Arabia.
    Alfayez OM; Alsallum AA; Aljabri AF; Almutairi FS; Al-Azzeh O; Almalki OS; Al Yami MS; Almohammed OA
    Front Public Health; 2022; 10():989072. PubMed ID: 36159298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intersection of physician wellbeing and clinical application of diabetes guidelines.
    Seehusen DA; Deavers J; Mainous AG; Ledford CJW
    Patient Educ Couns; 2018 May; 101(5):894-899. PubMed ID: 29248167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Care Providers' Prediabetes Screening, Testing, and Referral Behaviors.
    Nhim K; Khan T; Gruss SM; Wozniak G; Kirley K; Schumacher P; Luman ET; Albright A
    Am J Prev Med; 2018 Aug; 55(2):e39-e47. PubMed ID: 29934016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Prescription for Insured Adults With Prediabetes From 2010 to 2012.
    Rodriguez-Gutierrez R; Montori VM
    Ann Intern Med; 2015 Sep; 163(6):482-3. PubMed ID: 26370016
    [No Abstract]   [Full Text] [Related]  

  • 17. Survey of primary care providers' knowledge of screening for, diagnosing and managing prediabetes.
    Tseng E; Greer RC; O'Rourke P; Yeh HC; McGuire MM; Clark JM; Maruthur NM
    J Gen Intern Med; 2017 Nov; 32(11):1172-1178. PubMed ID: 28730532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Should Not Be Used to Treat Prediabetes.
    Davidson MB
    Diabetes Care; 2020 Sep; 43(9):1983-1987. PubMed ID: 32936780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rural physicians' perspectives on cervical and breast cancer screening: a gender-based analysis.
    Ahmad F; Stewart DE; Cameron JI; Hyman I
    J Womens Health Gend Based Med; 2001 Mar; 10(2):201-8. PubMed ID: 11268303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of clinical practice guidelines should not be overestimated.
    Lember M; Rätsep A; Kalda R; Oja I
    J Am Board Fam Pract; 2004; 17(6):474-5; author reply 475. PubMed ID: 15575042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.